7.63
1.55%
-0.12
Pre-market:
7.76
0.13
+1.70%
Ginkgo Bioworks Holdings Inc stock is traded at $7.63, with a volume of 667.61K.
It is down -1.55% in the last 24 hours and down -8.40% over the past month.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.
See More
Previous Close:
$7.75
Open:
$7.72
24h Volume:
667.61K
Relative Volume:
0.48
Market Cap:
$424.04M
Revenue:
$251.46M
Net Income/Loss:
$-892.87M
P/E Ratio:
-10.75
EPS:
-0.71
Net Cash Flow:
$-336.30M
1W Performance:
-7.74%
1M Performance:
-8.40%
6M Performance:
-80.03%
1Y Performance:
-88.37%
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Name
Ginkgo Bioworks Holdings Inc
Sector
Industry
Phone
(877) 442-5362
Address
27 DRYDOCK AVENUE, BOSTON
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
May-15-24 | Downgrade | BTIG Research | Neutral → Sell |
May-10-24 | Downgrade | William Blair | Mkt Perform → Underperform |
Nov-14-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
Nov-09-23 | Downgrade | BTIG Research | Buy → Neutral |
Jun-02-23 | Downgrade | Goldman | Neutral → Sell |
May-11-23 | Downgrade | William Blair | Outperform → Mkt Perform |
Nov-29-22 | Initiated | Berenberg | Buy |
Oct-04-22 | Initiated | Morgan Stanley | Equal-Weight |
May-18-22 | Downgrade | BofA Securities | Neutral → Underperform |
Mar-02-22 | Resumed | Cowen | Outperform |
Feb-23-22 | Initiated | Goldman | Neutral |
Feb-01-22 | Initiated | BofA Securities | Neutral |
Jan-28-22 | Initiated | BofA Securities | Buy |
Jan-07-22 | Initiated | BTIG Research | Buy |
Nov-29-21 | Initiated | Jefferies | Buy |
Oct-13-21 | Initiated | Raymond James | Outperform |
Oct-12-21 | Initiated | William Blair | Outperform |
Sep-20-21 | Initiated | HSBC Securities | Buy |
View All
Ginkgo Bioworks Holdings Inc Stock (DNA) Latest News
Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation - Marketscreener.com
Vanguard Group Inc's Strategic Reduction in Ginkgo Bioworks Holdings Inc - GuruFocus.com
Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market - MSN
With 48% ownership, Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has piqued the interest of institutional investors - Yahoo Finance
Ginkgo Bioworks (DNA): A Leader in Cell Programming and Genetic Diagnostics - Insider Monkey
10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds - Insider Monkey
Ginkgo Bioworks Holdings, Inc. (DNA) Outpaces Stock Market Gains: What You Should Know - MSN
Forbes J M & Co. LLP Invests $1.02 Million in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
PFG Investments LLC Invests $1.54 Million in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Major Boston biotech company begins layoffs this week - MSN
Ginkgo Bioworks (NYSE:DNA) Shares Up 5%Here's What Happened - MarketBeat
Equitec Proprietary Markets LLC Has $99,000 Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Sees Significant Growth in Short Interest - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Trading 5.9% HigherStill a Buy? - MarketBeat
Exchange Traded Concepts LLC Has $2.99 Million Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now? - MSN
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by Squarepoint Ops LLC - MarketBeat
Algert Global LLC Takes $36,000 Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Receives $4.16 Consensus Target Price from Analysts - MarketBeat
Ginkgo Bioworks Holdings Inc (DNA) Q2 2024 Earnings Call Highlights: Strategic Restructuring ... By GuruFocus - Investing.com Canada
Ginkgo Bioworks executive sells over $10k in company stock By Investing.com - Investing.com Australia
Ginkgo Bioworks exec sells over $2500 in stock By Investing.com - Investing.com Canada
Ginkgo Bioworks executive sells over $10k in company stock - Investing.com
Ginkgo Bioworks exec sells over $2500 in stock - Investing.com
Transforming Healthcare From The Inside Out, Nanorobots Are Revolutionizing Treatment With Precision At The Nanoscale: A Report by TNR, The Niche Research - GlobeNewswire Inc.
Green Alpha Advisors LLC Decreases Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Mackenzie Financial Corp Takes Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Lesaffre strengthens its Research, Development & Innovation (RD&I) with the acquisition of Altar, a company owned by Ginkgo Bioworks - Yahoo Finance
Where are the Opportunities in (DNA) - Stock Traders Daily
Revenues Tell The Story For Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) As Its Stock Soars 33% - Simply Wall St
Virica Biotech and Ginkgo Bioworks Announce Partnership to Accelerate AAV Gene Therapy Manufacturing - Yahoo Finance
Renaissance Technologies LLC Makes New $2.13 Million Investment in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
After Plunging -40.22% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA) - MSN
Nanobots in Healthcare Research Report 2024: A $7.1 Billion Market in 2023Global Forecast to 2030 - GlobeNewswire Inc.
Rhumbline Advisers Sells 1,331,930 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Wellington Wealth Strategies LLC. Makes New Investment in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Benjamin F. Edwards & Company Inc. Raises Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - Defense World
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Stock Position Lifted by Benjamin F. Edwards & Company Inc. - MarketBeat
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN
933,898 Shares in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Purchased by XTX Topco Ltd - MarketBeat
(DNA) Trading Advice - Stock Traders Daily
Novus, Ginkgo Bioworks partner to develop new feed additives - FeedStrategy.com
NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture - PR Newswire
What's Going On With Ginkgo Bioworks Stock This Week? - MSN
Ginkgo Bioworks (NYSE:DNA) PT Raised to $10.00 at TD Cowen - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Shares Down 6.4% - MarketBeat
Ginkgo Bioworks Holdings Inc Stock (DNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):